Author

Anjela Tzontcheva 1

1 Merck & Co., Inc.,Rahway,United States

QUALITY OF LIFE OUTCOMES FROM PURSUIT-M TRIAL FURTHER SUPPORT EARLY DOSE OPTIMIZATION OF GOLIMUMAB IN MODERATE-TO-SEVERE ACTIVE ULCERATIVE COLITIS

Amy Puenpatom, Ping Xu, Anjela Tzontcheva, Tony Terzis, Alan Meehan, Cindy L J Weinstein

Item 1 - 1 / 1
1